AAAAAA

   
Results: 1-15 |
Results: 15
Epidemiology of NSAID-related gastroduodenal mucosal injury
Authors: Aalykke, C Lauritsen, K
Citation: C. Aalykke et K. Lauritsen, Epidemiology of NSAID-related gastroduodenal mucosal injury, BEST PR RES, 15(5), 2001, pp. 705-722
Aspects of non-steroidal anti-inflammatory drug therapy - Preface
Authors: Lauritsen, K Rask-Madsen, J
Citation: K. Lauritsen et J. Rask-madsen, Aspects of non-steroidal anti-inflammatory drug therapy - Preface, BEST PR RES, 15(5), 2001, pp. VII-VII
Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6months
Authors: Talley, NJ Lauritsen, K Tunturi-Hihnala, H Lind, T Moum, B Bang, C Schulz, T Omland, TM Delle, M Junghard, O
Citation: Nj. Talley et al., Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6months, ALIM PHARM, 15(3), 2001, pp. 347-354
Switch from systemic steroids to budesonide in steroid dependent patients with inactive Crohn's disease
Authors: Cortot, A Colombel, JF Rutgeerts, P Lauritsen, K Malchow, H Hamling, J Winter, T Van Gossum, A Persson, T Pettersson, E
Citation: A. Cortot et al., Switch from systemic steroids to budesonide in steroid dependent patients with inactive Crohn's disease, GUT, 48(2), 2001, pp. 186-190
One-week triple therapy with esomeprazole provides effective eradication of Helicobacter pylori in duodenal ulcer disease
Authors: Van Zanten, SV Lauritsen, K Delchier, J Labenz, J De Argila, CM Lind, T Treichel, HC Stubberod, A Cockeram, A Hasselgren, G Gothe, L Wrangstadh, M Sinclair, P
Citation: Sv. Van Zanten et al., One-week triple therapy with esomeprazole provides effective eradication of Helicobacter pylori in duodenal ulcer disease, ALIM PHARM, 14(12), 2000, pp. 1605-1611
Switch from systemic steroids to budesonide in steroid-dependent patients with inactive Crohn's disease
Authors: Cortot, A Colombel, JF Rutgeerts, P Lauritsen, K Malchow, H Hamling, J Winter, T van Gossum, A Persson, T Pettersson, E
Citation: A. Cortot et al., Switch from systemic steroids to budesonide in steroid-dependent patients with inactive Crohn's disease, DRUGS TODAY, 36, 2000, pp. 33-37
H. pylori and risk of ulcer bleeding among users of NSAIDs - Reply
Authors: Aalykke, C Hallas, J Lauritsen, K
Citation: C. Aalykke et al., H. pylori and risk of ulcer bleeding among users of NSAIDs - Reply, GASTROENTY, 118(2), 2000, pp. 451-452
Eradication of Helicobacter pylori in functional dyspepsia - Reply
Authors: Talley, NJ Lauritsen, K Bolling-Sternevald, E
Citation: Nj. Talley et al., Eradication of Helicobacter pylori in functional dyspepsia - Reply, BR MED J, 319(7207), 1999, pp. 451-452
Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up
Authors: Talley, NJ Janssens, J Lauritsen, K Racz, I Bolling-Sternevald, E
Citation: Nj. Talley et al., Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up, BR MED J, 318(7187), 1999, pp. 833-837
Omeprazole and ranitidine in the prevention of relapse in patients with duodenal ulcer disease
Authors: Lauritsen, K Rutgersson, K Bolling, E Brunner, G Eriksson, S Galmiche, JP Walan, A Archambault, AP Gudjonsson, H Bailey, RJ Porro, GB Frison, L Havu, N Thomspon, ABR
Citation: K. Lauritsen et al., Omeprazole and ranitidine in the prevention of relapse in patients with duodenal ulcer disease, CAN J GASTR, 13(10), 1999, pp. 806-813
On demand therapy with omeprazole for the long-term management of patientswith heartburn without oesophagitis - a placebo-controlled randomized trial
Authors: Lind, T Havelund, T Lundell, L Glise, H Lauritsen, K Pedersen, SA Anker-Hansen, O Stubberod, A Eriksson, G Carlsson, R Junghard, O
Citation: T. Lind et al., On demand therapy with omeprazole for the long-term management of patientswith heartburn without oesophagitis - a placebo-controlled randomized trial, ALIM PHARM, 13(7), 1999, pp. 907-914
An evidence-based appraisal of reflux disease management - the Genval workshop report
Authors: Dent, J Brun, J Fendrick, AM Fennerty, MB Janssens, J Kahrilas, PJ Lauritsen, K Reynolds, JC Shaw, M Talley, NJ
Citation: J. Dent et al., An evidence-based appraisal of reflux disease management - the Genval workshop report, GUT, 44, 1999, pp. S1-S16
Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidalanti-inflammatory drugs: A case-control study
Authors: Aalykke, C Lauritsen, JM Hallas, J Reinholdt, S Krogfelt, K Lauritsen, K
Citation: C. Aalykke et al., Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidalanti-inflammatory drugs: A case-control study, GASTROENTY, 116(6), 1999, pp. 1305-1309
Quality of life in patients with heartburn but without esophagitis: Effects of treatment with omeprazole
Authors: Havelund, T Lind, T Wiklund, I Glise, H Hernqvist, H Lauritsen, K Lundell, L Pedersen, SA Carlsson, R Junghard, O Stubberod, A Anker-Hansen, O
Citation: T. Havelund et al., Quality of life in patients with heartburn but without esophagitis: Effects of treatment with omeprazole, AM J GASTRO, 94(7), 1999, pp. 1782-1789
Validation of seven graded diary cards for severity of dyspeptic symptoms in patients with non ulcer dyspepsia
Authors: Junghard, O Lauritsen, K Talley, NJ Wiklund, IK
Citation: O. Junghard et al., Validation of seven graded diary cards for severity of dyspeptic symptoms in patients with non ulcer dyspepsia, EURO J SURG, 164, 1998, pp. 106-111
Risultati: 1-15 |